about
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.Catecholaminergic Polymorphic Ventricular TachycardiaAge and sex differences in human skeletal muscle: role of reactive oxygen speciesArrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9936-5808
@en
name
Barbara Colombi
@ast
Barbara Colombi
@en
Barbara Colombi
@es
Barbara Colombi
@nl
type
label
Barbara Colombi
@ast
Barbara Colombi
@en
Barbara Colombi
@es
Barbara Colombi
@nl
prefLabel
Barbara Colombi
@ast
Barbara Colombi
@en
Barbara Colombi
@es
Barbara Colombi
@nl
P106
P1153
6507550866
P21
P31
P496
0000-0001-9936-5808